Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake

Germline genetic testing is recommended for all patients with pancreatic cancer (PC) but uptake rates are low. We implemented a mainstreaming program in oncology clinics to increase testing for PC patients. Genetic counselors trained oncology providers to offer a standardized multigene panel and obt...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramsey, Mitchell L., Tomlinson, Jewel, Pearlman, Rachel, Abushahin, Laith, Aeilts, Amber, Chen, Hui-Zi, Chen, Yan, Compton, Ashley, Elkhatib, Rifat, Geiger, Levi, Hays, John, Jeter, Joanne, Jin, Ning, Malalur, Pannaga, Roychowdhury, Sameek, Ruple, Jessica, Prebish, Jennifer, Stanich, Peter P., Hampel, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204376/
https://www.ncbi.nlm.nih.gov/pubmed/35713757
http://dx.doi.org/10.1007/s10689-022-00300-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204376/
https://www.ncbi.nlm.nih.gov/pubmed/35713757
http://dx.doi.org/10.1007/s10689-022-00300-5

Ejemplares similares